Latest News about ALKS

Recent news which mentions ALKS

< Previous 1 2 3 4 5 Next >

BioCorRx Aims To Help Combat Opioid Crisis With Implantable Naltrexone Drug Candidate BICX104

January 24, 2022

The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug

January 20, 2022

Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2021

December 01, 2021

Direxion Launches New Nanotechnology ETF, TYNE

November 23, 2021

75 Biggest Movers From Yesterday

November 10, 2021

Janssen Partially Terminates Nanoparticle License Agreement With Alkermes

November 09, 2021

Why Alkermes Stock Is Sinking Today

November 09, 2021

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data

November 09, 2021

7 A-Rated Healthcare Stocks to Buy for the Long Haul

November 01, 2021

10 Biggest Price Target Changes For Thursday

October 28, 2021

Alkermes plc (ALKS) Q3 2021 Earnings Call Transcript

October 27, 2021

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More

October 24, 2021

3 Mid-Cap Stocks With Large-Cap Potential

October 15, 2021

2 Supercharged Stocks Near 52-Week Highs Despite the Market Pullback

October 13, 2021

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs

October 08, 2021

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug

September 29, 2021

Benzinga's Bulls And Bears Of The Week: Alibaba, Apple, Nio, PayPal, Verizon And More

September 04, 2021

BofA Downgrades Alkermes After Stock Rally: 'We Don't See A Favorable Catalyst Pathway'

September 02, 2021

Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2021

September 02, 2021

12 Health Care Stocks Moving In Thursday's Pre-Market Session

September 02, 2021

The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering

September 01, 2021

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical

August 31, 2021

The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration

August 27, 2021

The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal

August 24, 2021

Stocks That Hit 52-Week Highs On Monday

August 23, 2021

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data

August 20, 2021

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck

August 19, 2021

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline

August 18, 2021

The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO

August 13, 2021

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO

August 06, 2021

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.